- Home
- CNTA vs VRNS Comparison
CNTA vs VRNS Comparison
Compare CNTA & VRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$25.33
HOLD
Current Price
$33.34
Company Overview
Basic Information| Metric | CNTA | VRNS |
|---|---|---|
| Founded | 2020 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.9B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CNTA | VRNS |
|---|---|---|
| Price | $25.33 | $33.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 19 |
| Target Price | $37.70 | ★ $60.68 |
| AVG Volume (30 Days) | 1.3M | ★ 2.3M |
| Earning Date | 11-05-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,000,000.00 | ★ $608,677,000.00 |
| Revenue This Year | N/A | $14.57 |
| Revenue Next Year | N/A | $15.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 118.88 | 11.37 |
| 52 Week Low | $9.60 | $30.02 |
| 52 Week High | $30.58 | $63.90 |
Technical Indicators
Market Signals| Indicator | CNTA | VRNS |
|---|---|---|
| Relative Strength Index (RSI) | 42.85 | 44.35 |
| Support Level | $24.17 | $32.63 |
| Resistance Level | $26.01 | $34.75 |
| Average True Range (ATR) | 1.20 | 1.10 |
| MACD | -0.37 | 0.62 |
| Stochastic Oscillator | 19.03 | 68.43 |
Price Performance
Historical Comparison CNTA
VRNS
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About VRNS Varonis Systems Inc.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.